 |
|
|
| |
High Efficacy of Sofosbuvir in Combination with Weight Based Ribavirin for 24 weeks in Difficult to Treat HCV Infected Genotype-1 Patients
|
| |
| |
Reported by Jules Levin
CROI 2013 Atlanta March 3-6
1,2 Osinusi A, 2Meissner E.G, 3Bon D, 2Lee YJ, 2Proschan M,3Herrmann E, 4Teferi G, 5Talwani R, 6Symonds W.T, 2Polis M, 6McHutchison J, 2Fauci AS, 7Masur H, 2Kottilil S and the NIAID SPARE Study team
1CMRP, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, 2NIAID, NIH, Bethesda, MD, 3IBBM, Johann Wolfgang Goethe University Frankfurt, 4Unity Health Care Inc, 5University of Maryland Medical Center, Baltimore, MD, 6Gilead Sciences, Foster City, CA, 7CCMD, Clinical Centre, NIH, Bethesda, MD
|
| |
|
|
|
|
|
